Sanofi to establish mRNA vaccine center with 400 employees

Sanofi Pasteur will launch a dedicated center for research into and the development, production and quality control of mRNA vaccines. The center will have 400 employees and an annual budget of around DKK 3bn.

The vaccine division of the pharmaceutical company Sanofi is now betting everything it has on becoming a leading actor in the market for mRNA vaccines, according to a Tuesday press release.

The company plans to establish a new center with 400 employees which will carry out all processes involving the mRNA vaccines including research, development, production and quality control.

Read the whole article

Get 14 days free access.
No credit card required.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

"Real world" patient data documents the long-term effects of ALK vaccines

In the largest study ever of its kind, patient data from the "real world" documents the long-term effects of up to nine years of ALK vaccines. Up until now, it has not been possible to demonstrate these in ordinary clinical studies where the follow-up period is shorter, and the new knowledge could be a turning point in ALK's dialog about prices and subsidies with authorities and payers. 

Further reading

Related articles

Latest news

See all jobs